来那替尼
富维斯特朗
转移性乳腺癌
医学
癌症
肿瘤科
乳腺癌
癌症研究
内科学
作者
Cynthia X. Ma,Jingqin Luo,Rachel A. Freedman,Timothy J. Pluard,Julie R. Nangia,Janice Lu,Frances Valdez-Albini,Melody Cobleigh,Jason M. Jones,Nancy U. Lin,Eric P. Winer,P. Kelly Marcom,Shana Thomas,Jill Anderson,Brittney Haas,Leslie Bucheit,Richard Bryce,Alshad S. Lalani,Lisa A. Carey,Matthew P. Goetz
标识
DOI:10.1158/1078-0432.ccr-21-3418
摘要
Neratinib and fulvestrant are active for ER+/HER2mut MBC. Our data support further evaluation of dual HER2 blockade for the treatment of HER2mut MBC.
科研通智能强力驱动
Strongly Powered by AbleSci AI